Welcome to our dedicated page for Plexus news (Ticker: PLXS), a resource for investors and traders seeking the latest updates and insights on Plexus stock.
Plexus Corp. designs, manufactures and services complex products for customers in demanding regulatory environments. Its lifecycle solutions include design and development, supply chain services, new product introduction, manufacturing and sustaining services for the Aerospace/Defense, Healthcare/Life Sciences and Industrial sectors, including medical devices, aerospace and defense products, industrial automation systems and semiconductor capital equipment.
Company news commonly covers quarterly and annual results, revenue and earnings guidance, manufacturing program wins, customer manufacturing partnerships, free cash flow, share repurchases, leadership transitions and investor conference participation. Updates also reference segment and market-sector demand across the company's global electronics manufacturing and product-realization operations.
Plexus (NASDAQ: PLXS) released its Fiscal 2025 Sustainability Report, highlighting a shift from intensity-based metrics to absolute emissions reduction targets by 2033. The report covers environmental, social and governance progress, aligning climate strategy with international standards while supporting long-term growth and shareholder value.
Key highlights include more than doubling zero waste sites to eight locations, over $1.4 million in community contributions, enhanced mental health support, and improved disclosure alignment with GRI and TCFD frameworks.
Plexus (NASDAQ: PLXS) announced that CFO Patrick Jermain will retire after 15+ years with the company, including 12 years as CFO. David Abuhl, currently SVP-Finance, will become Senior VP and CFO effective May 11, 2026. Mr. Jermain will advise through July 31, 2026 to ensure transition continuity.
Plexus (NASDAQ: PLXS) reported record fiscal Q2 2026 revenue of $1.164 billion and GAAP diluted EPS of $1.82. Non-GAAP adjusted EPS was $2.05 and adjusted operating margin was 6.0%. Q3 revenue guidance is $1.200–$1.250 billion with non-GAAP EPS guidance of $2.02–$2.18. The company generated $16.0 million free cash flow, recorded $355 million in annualized manufacturing wins, repurchased $20.6 million of shares and reported ROIC of 13.8% (economic return 4.8%).
Plexus (NASDAQ: PLXS) will release fiscal second quarter 2026 results after market close on Wednesday, April 29, 2026. Management will host a conference call on Thursday, April 30, 2026 at 8:30 a.m. ET to discuss results.
An audio webcast and accompanying slides will be available in the investor relations section of the company website, plexus.com; the webcast will be archived and available on demand for 12 months.
Plexus (NASDAQ: PLXS) will present at the Raymond James 47th Annual Institutional Investors Conference in Orlando on March 2, 2026. A fireside chat with Plexus management is scheduled for 10:25 a.m. ET and will be available via live webcast with a 90-day replay.
Investors can join the live webcast and access the replay through the provided webcast link.
Plexus (NASDAQ: PLXS) reported fiscal Q1 2026 revenue of $1.070 billion, GAAP diluted EPS of $1.51 and non-GAAP diluted EPS of $1.78. Q1 GAAP operating margin was 5.1% and adjusted operating margin was 5.8%. The company initiated Q2 revenue guidance of $1.110–$1.150 billion with non-GAAP EPS guidance of $1.80–$1.95. Plexus won 22 manufacturing programs representing $283 million annualized revenue, repurchased $22.4 million of stock (remaining authorization $62.6 million/b)), reported ROIC of and negative free cash flow of $50.6 million.
Plexus (NASDAQ: PLXS) will release its fiscal Q1 2026 results after market close on Wednesday, January 28, 2026.
Management will host a conference call to discuss results on Thursday, January 29, 2026 at 8:30 a.m. Eastern Time. An audio webcast and accompanying slides will be available in the investor relations section of the company website, plexus.com, with the webcast link provided for live access and an on-demand replay archived for 12 months.
Investor contact: Shawn Harrison at +1.920.969.6325 or shawn.harrison@plexus.com.
Evolv Technology (NASDAQ: EVLV) announced a strategic contract manufacturing partnership with Plexus (NASDAQ: PLXS) to scale production and global supply-chain capabilities for Evolv's AI-based security screening products.
Key benefits cited include increased manufacturing capacity, a scalable international production platform, cost-saving procurement efficiencies, sustaining services to access new markets, and improved resiliency via geographic redundancy and 24/7 support. Plexus is described as operating 26 facilities with a global team of over 20,000. Evolv says it maintains ample inventory and committed production capacity while onboarding Plexus.
Plexus (NASDAQ: PLXS) reported fiscal Q4 (ended Sep 27, 2025) revenue of $1.058B, GAAP diluted EPS of $1.87 and non-GAAP diluted EPS of $2.14. Fiscal 2025 revenue was $4.033B with GAAP EPS $6.26 and non-GAAP EPS $7.43. Q4 free cash flow was $97M; FY2025 free cash flow was $154M. ROIC was 14.6% producing an economic return of 5.7% above WACC. The company repurchased $65M of shares in FY2025 and repurchased $21.5M in Q4; $85M remains under the $100M authorization. Q1 FY2026 guidance: revenue $1.050B–$1.090B and non-GAAP EPS $1.66–$1.81.
Plexus (NASDAQ: PLXS) has scheduled its fiscal fourth quarter and fiscal year 2025 earnings release for Wednesday, October 22, 2025, after market close. The company will host a conference call to discuss the results on Thursday, October 23, 2025, at 8:30 a.m. Eastern Time.
The earnings discussion will be accessible through a live webcast in the investor relations section of plexus.com. The webcast recording will remain available on-demand for 12 months following the event.